Raymond James Financial Services Advisors’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-18,229	Closed	-$41K	–	3162
2020 Q4	$41K	Buy	+18,229	New	+$41K	﹤0.01%	2909
2018 Q3	–	Sell	-10,733	Closed	-$68K	–	2809
2018 Q2	$68K	Buy	+10,733	New	+$68K	﹤0.01%	2640